These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 14674053

  • 1. An open-label study of nefazodone treatment of major depression in patients with congestive heart failure.
    Lespérance F, Frasure-Smith N, Laliberté MA, White M, Lafontaine S, Calderone A, Talajic M, Rouleau JL.
    Can J Psychiatry; 2003 Nov; 48(10):695-701. PubMed ID: 14674053
    [Abstract] [Full Text] [Related]

  • 2. Nefazodone treatment of major depression in alcohol-dependent patients: a double-blind, placebo-controlled trial.
    Roy-Byrne PP, Pages KP, Russo JE, Jaffe C, Blume AW, Kingsley E, Cowley DS, Ries RK.
    J Clin Psychopharmacol; 2000 Apr; 20(2):129-36. PubMed ID: 10770449
    [Abstract] [Full Text] [Related]

  • 3. Responders to antidepressant drug treatment: a study comparing nefazodone, imipramine, and placebo in patients with major depression.
    Cohn CK, Robinson DS, Roberts DL, Schwiderski UE, O'Brien K, Ieni JR.
    J Clin Psychiatry; 1996 Apr; 57 Suppl 2():15-8. PubMed ID: 8626358
    [Abstract] [Full Text] [Related]

  • 4. An open-label trial of nefazodone in high comorbidity panic disorder.
    DeMartinis NA, Schweizer E, Rickels K.
    J Clin Psychiatry; 1996 Jun; 57(6):245-8. PubMed ID: 8666561
    [Abstract] [Full Text] [Related]

  • 5. The effects of nefazodone on women with seasonal affective disorder: clinical and polysomnographic analyses.
    Shen J, Kennedy SH, Levitan RD, Kayumov L, Shapiro CM.
    J Psychiatry Neurosci; 2005 Jan; 30(1):11-6. PubMed ID: 15644992
    [Abstract] [Full Text] [Related]

  • 6. Fast onset: an open study of the treatment of major depressive disorder with nefazodone and pindolol combination therapy.
    Bakish D, Hooper CL, Thornton MD, Wiens A, Miller CA, Thibaudeau CA.
    Int Clin Psychopharmacol; 1997 Mar; 12(2):91-7. PubMed ID: 9219044
    [Abstract] [Full Text] [Related]

  • 7. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [Abstract] [Full Text] [Related]

  • 8. Antidepressant efficacy in HIV-seropositive outpatients with major depressive disorder: an open trial of nefazodone.
    Elliott AJ, Russo J, Bergam K, Claypoole K, Uldall KK, Roy-Byrne PP.
    J Clin Psychiatry; 1999 Apr; 60(4):226-31. PubMed ID: 10221282
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The effects of psychotherapy, nefazodone, and their combination on subjective assessment of disturbed sleep in chronic depression.
    Manber R, Rush AJ, Thase ME, Amow B, Klein D, Trivedi MH, Korenstein SG, Markowitz JC, Dunner DL, Munsaka M, Borian FE, Martin, Keller B.
    Sleep; 2003 Mar 15; 26(2):130-6. PubMed ID: 12683470
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Three- to four-year follow-up to an open trial of nefazodone for combat-related posttraumatic stress disorder.
    Hertzberg MA, Feldman ME, Beckham JC, Moore SD, Davidson JR.
    Ann Clin Psychiatry; 2002 Dec 15; 14(4):215-21. PubMed ID: 12630657
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Nefazodone in the treatment of elderly patients with depressive disorders: a prospective, observational study.
    Saiz-Ruiz J, Ibañez A, Díaz-Marsá M, Arias F, Carrasco JL, Huertas D, Martín-Carrasco M, Moreno I, Rico-Villademoros F.
    CNS Drugs; 2002 Dec 15; 16(9):635-43. PubMed ID: 12153334
    [Abstract] [Full Text] [Related]

  • 16. A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression.
    Barbee JG, Thompson TR, Jamhour NJ, Stewart JW, Conrad EJ, Reimherr FW, Thompson PM, Shelton RC.
    J Clin Psychiatry; 2011 Oct 15; 72(10):1405-12. PubMed ID: 21367355
    [Abstract] [Full Text] [Related]

  • 17. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
    Wohlreich MM, Mallinckrodt CH, Prakash A, Watkin JG, Carter WP.
    Depress Anxiety; 2007 Oct 15; 24(1):41-52. PubMed ID: 16845641
    [Abstract] [Full Text] [Related]

  • 18. Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction.
    Feiger A, Kiev A, Shrivastava RK, Wisselink PG, Wilcox CS.
    J Clin Psychiatry; 1996 Oct 15; 57 Suppl 2():53-62. PubMed ID: 8626364
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression.
    Gelenberg AJ, Trivedi MH, Rush AJ, Thase ME, Howland R, Klein DN, Kornstein SG, Dunner DL, Markowitz JC, Hirschfeld RM, Keitner GI, Zajecka J, Kocsis JH, Russell JM, Miller I, Manber R, Arnow B, Rothbaum B, Munsaka M, Banks P, Borian FE, Keller MB.
    Biol Psychiatry; 2003 Oct 15; 54(8):806-17. PubMed ID: 14550680
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.